NEU 2.37% $19.39 neuren pharmaceuticals limited

Ann: Q4 2023 Appendix 4C Cash Flow Report, page-14

  1. 2,374 Posts.
    lightbulb Created with Sketch. 739
    Running of trials is often contracted out these days so imv the fact there is no human resources ramp up tells us.......nothing
    @seanc
    Last edited by nashezz: 01/02/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.